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A B S T R A C T
Mitochondria possess a proteolytic system that contributes to the regulation of mitochondrial dynamics,
mitochondrial biogenesis and mitophagy. We aimed at the identiﬁcation by bottom-up proteomics of
altered protein processing due to the activation of mitochondrial proteases in a cellular model of
impaired dopamine homeostasis. Moreover, we optimized the conditions for top-down proteomics to
identify the cleavage site sequences.
ã 2016 The Authors. Published by Elsevier B.V. on behalf of European Proteomics Association (EuPA). This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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journal homepa ge: www.elsev ier .com/locate /euprotProteomics and genomics investigations for the identiﬁcation
and characterization of proteases and their substrates are globally
referred to as degradomics. Proteases are not only involved in the
degradation of unfolded or damaged proteins, but serve to provide
a system by which protein function is regulated. Indeed, proteases
catalyze an irreversible hydrolysis reaction regulating activity and
localisation of many proteins [1]. Mitochondria possess a highly
conserved, intraorganelle proteolytic system that conducts the
surveillance of protein quality control within mitochondria [2].
These proteases degrade damaged or unfolded proteins to
peptides, which are subsequently either transferred out of the
organelle or further degraded by mitochondrial oligopeptidases
[3]. In addition to their conventional role in the degradation of
misfolded or damaged mitochondrial proteins, many mitochon-
drial proteases take part in the regulation of proteins that
orchestrate mitochondrial dynamics, mitochondrial biogenesis
and mitophagy [4]. An alteration of mitochondrial proteases
activity is detrimental to cell health and has been linked to aging* Corresponding authors at: Department of Science and High Technology,
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).and to various diseases, including neurological disorders like
spinocerebellar ataxia and Parkinson's disease (PD) [5,6]. Indeed,
mutations in the mitochondrial serine protease HTRA2 have been
associated with PD in sporadic patients [7]. We previously reported
a selective degradation of voltage-dependent anion-selective
channel proteins (VDACs) induced by dopamine toxicity, in a
cellular model of PD [8]. However, by the combination of gel-based
and gel-free techniques, we observed an accumulation of VDACs
proteolytic fragments inside mitochondria, together with proteo-
lytic fragments belonging to other mitochondrial proteins [9].
These ﬁndings suggested that the impairment of dopamine
homeostasis, one of the putative causes of sporadic PD, could
induce an alteration of mitochondrial protease functions, deeply
compromising the mitochondrial quality control systems. From
this point of view, a more comprehensive characterization of
mitochondrial proteases could provide new insights into PD
pathogenesis.
This work was developed in the context of the biology and
disease action of the mitochondrial human proteome project (mt-
HPP) [10]. To understand protease functions it is of primary
importance to determine their substrates and their cleavage site(s).
In order to identify which substrates were differentially processed
by mitochondrial proteases in a cellular model for the impairment
of dopamine homeostasis [11], we combined an in-gelics Association (EuPA). This is an open access article under the CC BY-NC-ND license
2 A. Di Pierro et al. / EuPA Open Proteomics 11 (2016) 1–3fractionation of mitochondrial proteins, followed by shotgun
proteomics of selected molecular weight ranges.
SH-SY5Y human neuroblastoma cells were treated or not with
250 mM dopamine, in the presence of 700 U/mL of catalase for 24 h,
in three independent replicates per condition. Mitochondrial
enriched fractions were obtained by differential centrifugation
according to standardized guidelines developed by the mt-HPP
team [9]. Samples were lysed in RIPA buffer (50 mM Tris-HCl pH
7.6, 150 mM NaCl, 1% sodium deoxycholate, 1% NP-40 and 0.1% SDS)
and 30 mg of mitochondrial proteins were separated by SDS-PAGE
electrophoresis on acrylamide/bisacrylamide 16% gel. Three slices
in different molecular weight ranges (i.e., 40–25, 25–15 and 15–
10 kDa) were manually excised (Fig. 1A), washed twice with
100 mM NH4HCO3 in 50% v/v acetonitrile (ACN) for 10 min and
subjected to trypsin digestion. Cysteines were reduced with 10 mM
DTT in 100 mM NH4HCO3 for 45 min at 56 C and alkylated with
55 mM iodoacetamide (IAA) in 100 mM NH4HCO3 at room
temperature for 30 min in the dark. Gel slices were washed twice
as described above and dried in a vacuum centrifuge. The dry gel
pieces were incubated with digestion buffer (12 ng/mL porcine
trypsin, 100 mM NH4HCO3, 10 mM CaCl2 and 5% ACN) overnight at
37 C. After a brief centrifugation, supernatants containing hydro-
phylic peptides were saved in a new microcentrifuge tube.
Hydrophobic peptides were extracted by adding 1% triﬂuoroacetic
acid (TFA) and incubating at room temperature for 10 minutes in
agitation. Supernatants were collected and pooled with the ﬁrst
ones. Eventually, 60% v/v ACN and 0.1% v/v TFA were added to the
gel pieces and after 10 minutes vortexing the supernatants were
collected, pooled together and vacuum dried. The digested samples
were analyzed by nano LC-MS/MS using a Proxeon EASY-nLCII
(Thermo Fisher Scientiﬁc, Milan, Italy) coupled to the maXis HD
UHR-TOF mass spectrometer (Bruker Daltonics). Five mL of sample
were injected and concentrated on a trapping C18-A1 EASY Column
(2 cm, 100 mm I.D., 5 mm p.s., Thermo Fisher Scientiﬁc). TrappedFig. 1. Bottom-up analysis of mitochondrial proteolytic fragments. (A) Schematic repres
40–25, 25–15 and 15–10 kDa). (B) HSPD1 proteolytic peptide levels in the 40–25 kDa fra
25 kDa fraction (bottom) and 25–15 kDa (top). CTR: cells under control conditions, DA
replicates. For further details see text.peptides were subsequently separated on a C18-Acclaim PepMap
(25 cm, 75 mm I.D., 5 mm p.s., Thermo Fisher Scientiﬁc) at 0.3 mL/
min with a gradient from 2 to 45% B in 20 min (eluents: A, 0.1% FA in
H2O; B, 0.1% FA in CH3CN). The raw data were processed with
PEAKS 7.5 and searched against UniProt SwissProt database
(release 2015_03 including common MS contaminants 
20,441 entries). The tolerances for the mass error were set to
15 ppm and 0.05 Da for precursors and fragments respectively, two
missed cleavage allowed, carboamidomethylation of Cys as ﬁxed
modiﬁcation and oxidation of Met, deamidation of Asn and Gln and
acetylation of Lys were selected as variable modiﬁcations. 10logP
value for peptides was adjusted to provide an FDR lower than 0.1%
at peptide and protein level.
We employed a bottom-up approach to detect the proteins that
were present at a lower molecular weight compared to their
theoretical one, indicating a possible proteolytic processing.
Among all identiﬁed proteolytic fragments, only the mitochondrial
60 kDa heat shock protein (HSPD1) and the mitochondrial porin
VDAC1 showed a different behaviour between dopamine treated
cells and controls. Although HSPD1 resulted processed by
proteases in both conditions, with proteolytic fragments present
in all gel-fractions, dopamine induced an accumulation of
HSPD1 peptides in the 25–15 kDa region (Fig. 1B). In line with
our previous reports [8,9], dopamine induced a decrease of full
length VDAC1 (30 kDa) along with an accumulation of VDAC1 small
peptides (in the 25–15 kDa fraction) inside mitochondria (Fig. 1C).
Since all peptides identiﬁed by shotgun proteomics were
trypsin digested, we were not able to reconstruct the aminoacidic
sequence of processed substrates, so to detect the consensus site of
proteases. To overcome these limitations and identify proteolytic
fragments generated in the mitochondria after dopamine treat-
ment, we moved towards a top-down approach, where proteins are
separated by electrophoretic or chromatographic techniques
without any prior digestion of the sample. However, theentation of gel slicing in three fractions with different molecular weight range (i.e.,
ction (bottom) and 25–15 kDa (top). (C) VDAC1 proteolytic peptide levels in the 40–
: cells treated with 250 mM dopamine. Mean and SEM refer to three independent
Fig. 2. Validation of the electroelution procedure. Prestained protein MW markers (70 and 55 kDa) were excised from an acrylamide/bisacrylamide 16% gel. After
elecroelution, samples were cleaned from SDS residues by ultraﬁltration (MWCO 3 kDa) with 20% v/v ethanol. Samples were vacuum dried, resuspended with Laemmli buffer
and separated by SDS-PAGE. First lane: 55 kDa marker; second lane: 70 kDa marker.
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lenges, especially for complex multiprotein samples, thus we
focused our efforts on establishing a reliable procedure for the
preparation of protein samples for top-down proteomics. We
decided to separate proteins through SDS–PAGE, cut thin slices at
the level of lower MW and electroelute each protein (or fragments)
out of the gel. To this purpose, a homemade electroeluter was
designed and assembled using a polymethylmethacrilate support,
milled to obtain the elution cell (1  2  0.2 cm). The cell was then
drilled to allow the insertion of two platinum electrodes, plugged
to a power supply. Electroelution condition setting was optimized
using prestained protein MW markers (PageRuler Plus Prestained
Protein Ladder, 10 to 250 kDa, Thermo-Scientiﬁc), separated in an
acrylamide/bisacrylamide 16% gel. Protein bands were manually
excised, placed in the eluter cell and covered with 200 mL elution
buffer (500 mM NH4HCO3). By applying a constant current (10 mA),
we observed that 20 min were needed to elute the 25 kDa protein-
marker, 25 min for the 35 kDa protein and 30 min for the 70 kDa
protein. The buffer was collected as soon as the gel bands became
colourless indicating the complete elution of the proteins. In order
to remove SDS residues that could interfere with subsequent MS
analysis, samples were added with 20% v/v ethanol and loaded into
an ultraﬁltration cell (Vivaspin 500 MWCO 3000 Da PES, Sartorius)
and centrifuged at 15000  g to a ﬁnal volume of 50 mL. Then,
retained samples were collected in new tubes and vacuum dried.
To verify the efﬁciency of the protein elution, dried samples were
re-suspended in Laemmli buffer and loaded on an acrylamide/
bisacrylamide 16% gel. After blue-silver staining [12], we observed
single protein bands at the same molecular weight of the eluted
proteins, conﬁrming that proteins were correctly eluted and
recovered (Fig. 2).
Future work will be devoted to the fragmentation of isolated
proteins to obtain sequence information. The availability of
terminal sequences of a proteolytic fragment by top-down analysis
could be used to identify the protease potentially responsible for
its formation using the Merops database (http://merops.sanger.ac.
uk/). In this database, for a speciﬁc protease are reported all its
substrates and vice versa. The information in the database is
retrieved from the literature, therefore some reported data might
not have physiological relevance.
As a whole, the present communication describes a strategy for
the identiﬁcation for cleaved protease substrates by combining ashotgun analysis of pre-fractionated low-molecular-weight pro-
tein components with electroelution of full-length proteins for
top-down characterization. The proposed procedure should
constitute a basis for both identiﬁcation and quantiﬁcation of
proteins that migrate at a molecular weight lower than that
expected, and the identiﬁcation of their sequence termini, thus
permitting the assessment of putative proteases responsible for
their cleavage.
References
[1] C. López-Otín, C.M. Overall, Protease degradomics: a new challenge for
proteomics, Nat. Rev. Mol. Cell Biol. 3 (2002) 509–519.
[2] M. Koppen, T. Langer, Protein degradation within mitochondria: versatile
activities of AAA proteases and other peptidases, Crit. Rev. Biochem. Mol. Biol.
42 (2007) 221–242.
[3] T. Tatsuta, T. Langer, Quality control of mitochondria: protection against
neurodegeneration and ageing, EMBO J. 27 (2008) 306–314.
[4] R. Anand, T. Langer, M.J. Baker, Proteolytic control of mitochondrial function
and morphogenesis, Biochim. Biophys. Acta 1833 (2013) 195–204.
[5] R. Shanbhag, G. Shi, J. Rujiviphat, G.A. McQuibban, The emerging role of
proteolysis in mitochondrial quality control and the etiology of Parkinson's
disease, Parkinsons Dis. 2012 (2012) 382175.
[6] P. Martinelli, E.I. Rugarli, Emerging roles of mitochondrial proteases in
neurodegeneration, Biochim. Biophys. Acta 1797 (2010) 1–10.
[7] K.M. Strauss, L.M. Martins, H. Plun-Favreau, F.P. Marx, S. Kautzmann, D. Berg, T.
Gasser, Z. Wszolek, T. Müller, A. Bornemann, H. Wolburg, J. Downward, O.
Riess, J.B. Schulz, R. Krüger, Loss of function mutations in the gene encoding
Omi/HtrA2 in Parkinson's disease, Hum. Mol. Genet. 14 (2005) 2099–2111.
[8] T. Alberio, C. Mammucari, G. D'Agostino, R. Rizzuto, M. Fasano, Altered
dopamine homeostasis differentially affects mitochondrial voltage-dependent
anion channels turnover, Biochim. Biophys. Acta 1842 (2014) 1816–1822.
[9] T. Alberio, H. Bondi, F. Colombo, I. Alloggio, L. Pieroni, A. Urbani, M. Fasano,
Mitochondrial proteomics investigation of a cellular model of impaired
dopamine homeostasis, an early step in Parkinson's disease pathogenesis, Mol.
Biosyst. 10 (2014) 1332–1344.
[10] A. Urbani, M. De Canio, F. Palmieri, S. Sechi, L. Bini, M. Castagnola, M. Fasano, A.
Modesti, P. Roncada, A.M. Timperio, L. Bonizzi, M. Brunori, F. Cutruzzolà, V. Di
Ilio, C. Di Ilio, G. Federici, F. Folli, S. Foti, C. Gelﬁ, D. Lauro, A. Lucacchini, F.
Magni, I. Messana, P.P. Pandolﬁ, S. Papa, P. Pucci,, P. Sacchetta, Italian Mt-Hpp
Study Group-Italian Proteomics Association (www. itpa. it), The mitochondrial
Italian Human Proteome Project initiative (mt-HPP), Mol. Biosyst. 9 (2013)
1984–1992.
[11] T. Alberio, L. Lopiano, M. Fasano, Cellular models to investigate biochemical
pathways in Parkinson's disease, FEBS J. 279 (2012) 1146–1155.
[12] G. Candiano, M. Bruschi, L. Musante, L. Santucci, G.M. Ghiggeri, B. Carnemolla,
P. Orecchia, L. Zardi, P.G. Righetti, Blue silver: a very sensitive colloidal
Coomassie G-250 staining for proteome analysis, Electrophoresis 25 (2004)
1327–1333.
